FDA Adverse Event Malfunction Summary report: N

BD VACUTAINER® LH PST¿ II PLUS BLOOD COLLECTION TUBES

MDR report key: 17909501 · Received October 10, 2023

Report

Report Number
9617032-2023-01402
Event Type
Malfunction
Date Received
October 10, 2023
Date of Event
September 15, 2023
Report Date
February 2, 2024
Manufacturer
BECTON, DICKINSON AND COMPANY (BD)
Product Code
JKA
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

B.3. DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD.

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION SUMMARY: RETENTION SAMPLES OF THE INCIDENT LOT WERE SELECTED FROM BD INVENTORY FOR EVALUATION AND UPON COMPLETION, NO ISSUES RELATING TO HEMOLYSIS OR ERRONEOUS RESULTS WERE OBSERVED. COMPLAINTS FOR SAMPLE QUALITY ARE UNDER STATISTICAL CONTROL FOR THE MONTH OF (B)(6) 2023. AT THIS TIME, FURTHER TESTING FOR HEMOLYSIS IS NOT INDICATED. CLINICAL TESTING FOR ERRONEOUS RESULTS (POTASSIUM) WAS PERFORMED ON LOT 3163205: NO DIFFICULTIES WERE ENCOUNTERED DURING BLOOD COLLECTION AND ALL TUBES APPEARED TO EXHIBIT PROPER FILL. BD WAS UNABLE TO DUPLICATE OR CONFIRM THE CUSTOMER¿S INDICATED FAILURE (ERRONEOUS RESULTS-POTASSIUM) BECAUSE THE DEFECT WAS NOT EVIDENT IN THE TESTING OF THE COMPLAINT LOT SAMPLES. ALL VISUAL OBSERVATIONS OF BOTH RETAIN AND CONTROL SAMPLES TESTED DEMONSTRATED CLINICALLY ACCEPTABLE PERFORMANCE. REPLICATES OF BOTH RETAIN AND CONTROL SAMPLES TESTED WERE ACCEPTABLE IN TERMS OF BOTH PRECISION AND ACCURACY. BASED ON A REVIEW OF THE DEVICE HISTORY RECORD FOR THE INCIDENT LOT, ALL PRODUCT SPECIFICATIONS AND REQUIREMENTS FOR LOT RELEASE WERE MET. THERE WERE NO RELATED QUALITY ISSUES DURING MANUFACTURING OF THE PRODUCT. THIS COMPLAINT IS UNABLE TO BE CONFIRMED FOR HEMOLYSIS AND ERRONEOUS RESULTS. BD WAS NOT ABLE TO IDENTIFY A ROOT CAUSE FOR THE INDICATED FAILURE MODE. FACTORS THAT MAY CONTRIBUTE TO ERRONEOUS RESULTS WERE EVALUATED THROUGH A CLINICAL STUDY TO VERIFY THE DESIGN OF THE DEVICE MET IT¿S INTENDED USE. THE RESULT OF THE STUDY SHOWED THAT THE DEVICE PERFORMED AS EXPECTED AND WE WERE UNABLE TO DETERMINE ANY EXTERNAL CONTRIBUTOR TO THIS REPORTED ISSUE. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED. OUR BUSINESS TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR IDENTIFICATION OF EMERGING TRENDS. BD QUALITY WILL CONTINUE TO MONITOR SAMPLE QUALITY COMPLAINTS.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS HAVE BEEN UPDATED WITH CORRECTED INFORMATION: THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR THE ADDITIONAL LOT NUMBER IS AS FOLLOWS.: D4. MEDICAL DEVICE LOT #: UNKNOWN. D4. MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. H4. DEVICE MANUFACTURE DATE: UNKNOWN. H.6. INVESTIGATION SUMMARY: BD HAD NOT RECEIVED SAMPLES OR PHOTOS FOR EVALUATION. ADDITIONALLY, BD WAS UNABLE TO DETERMINE THE SPECIFIC LOT NUMBER ASSOCIATED WITH THIS COMPLAINT; THEREFORE, A REVIEW OF THE DEVICE HISTORY RECORD COULD NOT BE CONDUCTED. THIS COMPLAINT IS UNABLE TO BE CONFIRMED FOR ERRONEOUS RESULTS OR HEMOLYSIS. IF ADDITIONAL INFORMATION IS MADE AVAILABLE, THIS COMPLAINT WILL BE REOPENED TO ASSESS THE LEVEL OF INVESTIGATION NEEDED. SAMPLE QUALITY COMPLAINTS FOR THE MONTH OF SEPTEMBER 2023 WERE UNDER STATISTICAL CONTROL. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED. OUR BUSINESS TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR IDENTIFICATION OF EMERGING TRENDS. BD QUALITY WILL CONTINUE TO MONITOR SAMPLE QUALITY COMPLAINTS.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD VACUTAINER® LH PST¿ II PLUS BLOOD COLLECTION TUBES THEY FOUND HEMOLYSIS AND ERRONEOUS RESULTS. THE FOLLOWING WAS REPORTED BY THE INITIAL REPORTER: CUSTOMER HIGHLIGHTED THAT THEY HAD A INCREASE OF HEMOLYSIS RATE, POTASSIUM . CUSTOMER CLAIMS THAT THEY HAVE HAD A INCREASED RATE OF HEMOLYSIS IN PST II TUBES. ONLY INFORMATION WE HAVE IS THAT FROM THIS WARD DURING WEEK 36 THEY GOT FROM 2% > 10% POTASSIUM. IT´S ONLY FROM 1 WARD THAT HIGHLIGHTED AN INCREASED HEMOLYSIS RATE. NO OTHER INFORMATION IS GIVEN, A MEETING WITH THE CUSTOMER WILL BE 09/20/2023 AND MORE INFORMATION WILL BE SHARED. UNKNOWN ANY IMPACT ON PATIENTS OR STAFF.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD VACUTAINER® LH PST¿ II PLUS BLOOD COLLECTION TUBES THEY FOUND HEMOLYSIS AND ERRONEOUS RESULTS. THE FOLLOWING WAS REPORTED BY THE INITIAL REPORTER: CUSTOMER HIGHLIGHTED THAT THEY HAD A INCREASE OF HEMOLYSIS RATE, POTASSIUM . CUSTOMER CLAIMS THAT THEY HAVE HAD A INCREASED RATE OF HEMOLYSIS IN PST II TUBES. ONLY INFORMATION WE HAVE IS THAT FROM THIS WARD DURING WEEK 36 THEY GOT FROM 2% > 10% POTASSIUM. IT´S ONLY FROM 1 WARD THAT HIGHLIGHTED AN INCREASED HEMOLYSIS RATE. NO OTHER INFORMATION IS GIVEN, A MEETING WITH THE CUSTOMER WILL BE (B)(6) 2023 AND MORE INFORMATION WILL BE SHARED. UNKNOWN ANY IMPACT ON PATIENTS OR STAFF.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD VACUTAINER® LH PST¿ II PLUS BLOOD COLLECTION TUBES THEY FOUND HEMOLYSIS AND ERRONEOUS RESULTS. THE FOLLOWING WAS REPORTED BY THE INITIAL REPORTER: CUSTOMER HIGHLIGHTED THAT THEY HAD A INCREASE OF HEMOLYSIS RATE, POTASSIUM . CUSTOMER CLAIMS THAT THEY HAVE HAD A INCREASED RATE OF HEMOLYSIS IN PST II TUBES. ONLY INFORMATION WE HAVE IS THAT FROM THIS WARD DURING WEEK 36 THEY GOT FROM 2% > 10% POTASSIUM. IT´S ONLY FROM 1 WARD THAT HIGHLIGHTED AN INCREASED HEMOLYSIS RATE. NO OTHER INFORMATION IS GIVEN, A MEETING WITH THE CUSTOMER WILL BE (B)(6) 2023 AND MORE INFORMATION WILL BE SHARED. UNKNOWN ANY IMPACT ON PATIENTS OR STAFF.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2163915 BD VACUTAINER® LH PST¿ II PLUS BLOOD COLLECTION TUBES BLOOD SPECIMEN COLLECTION DEVICE JKA BECTON, DICKINSON AND COMPANY (BD) SEE H. 10

Patients

Seq Age Sex Outcome Treatment
1 Unknown